Biofrontera Inc. Faces Delisting Concerns
Ticker: BFRIW · Form: 8-K · Filed: May 14, 2025 · CIK: 1858685
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
Related Tickers: BFRI
TL;DR
BFRI might get delisted - major red flag!
AI Summary
Biofrontera Inc. filed an 8-K on May 14, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on May 8, 2025. The company is incorporated in Delaware and its principal executive offices are located in Woburn, Massachusetts.
Why It Matters
This filing indicates potential issues with Biofrontera Inc.'s continued listing on an exchange, which could impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading status and investor confidence.
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- May 8, 2025 (date) — Earliest event reported
- May 14, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Woburn, Massachusetts (location) — Principal executive offices
FAQ
What specific listing rule or standard has Biofrontera Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Biofrontera Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest date of the event reported in this 8-K?
The earliest event reported in this 8-K was on May 8, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on May 14, 2025.
Where are Biofrontera Inc.'s principal executive offices located?
Biofrontera Inc.'s principal executive offices are located at 120 Presidential Way, Suite 330, Woburn, Massachusetts, 01801.
What is the Commission File Number for Biofrontera Inc.?
The Commission File Number for Biofrontera Inc. is 001-40943.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Biofrontera Inc. (BFRIW).